Sign up to create alerts for Instruments,
Economic Events and content by followed authors
Free Sign Up Already have an account? Sign In
Quotes
All Instrument Types
- All Instrument Types
- Indices
- Equities
- ETFs
- Funds
- Commodities
- Currencies
- Crypto
- Bonds
- Certificates
Please try another search
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Search Results for "ampy":
Results: 60
News
EnerCom is Pleased to Announce that Registration is Now Open for the 29th Annual EnerCom Denver - The Energy Investment Conference
By Investing.com
Investors are encouraged to register for EnerCom Denver “ The Energy Investment Conference featuring a broad group of public and private energy companies at www.enercomdenver.comEnerCom Denver “ The...
Acorda stock delisted after Chapter 11 filing
By Investing.com
PEARL RIVER – Acorda Therapeutics (OTC:ACORQ) Inc. has been delisted from the Nasdaq Stock Market due to non-compliance with certain listing rules, following the initiation of Chapter 11...
Acorda Therapeutics to be delisted from Nasdaq amid Chapter 11
By Investing.com
PEARL RIVER, N.Y. - Acorda Therapeutics , Inc. (NASDAQ:ACOR), a biotechnology company focused on developing therapies for neurological disorders, is set to be delisted from the Nasdaq Stock Market....
Analysis
Acorda's Shares Down On Disappointing Ampyra View For 2018
By Zacks Investment Research
Acorda Therapeutics, Inc. (NASDAQ:XOMA) and Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) . While Exelixis and XOMA sport a Zacks Rank #1 (Strong Buy), Sucampo carries a Zacks Rank #2 (Buy). You can...
Acorda Stops Post-Stroke Development Program On Ampyra
By Zacks Investment Research
Acorda Therapeutics, Inc. (NASDAQ:BIIB) for the development and commercialization of Ampyra in ex-U.S. markets under the trade name of Fampyra.According to Acorda, Ampyra is the first and only...
Acorda (ACOR) Q3 Earnings Top Estimates, Ampyra Sales View Up
By Zacks Investment Research
Acorda Therapeutics, Inc. (NASDAQ:CLBS) , both sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.Gilead Sciences’ earnings...
Results: 1
Refine Results
Instrument Type
Region
Sector
Industry
- All Industries
- Coal
- Oil & Gas
- Oil & Gas Related Equipment and Services
- Renewable Energy
- Uranium
- Chemicals
- Metals & Mining
- Construction Materials
- Paper & Forest Products
- Containers & Packaging
- Aerospace & Defense
- Machinery, Tools, Heavy Vehicles, Trains & Ships
- Construction & Engineering
- Diversified Industrial Goods Wholesale
- Professional & Commercial Services
- Freight & Logistics Services
- Passenger Transportation Services
- Transport Infrastructure
- Automobiles & Auto Parts
- Textiles & Apparel
- Homebuilding & Construction Supplies
- Household Goods
- Leisure Products
- Hotels & Entertainment Services
- Media & Publishing
- Diversified Retail
- Specialty Retailers
- Beverages
- Food & Tobacco
- Personal & Household Products & Services
- Food & Drug Retailing
- Consumer Goods Conglomerates
- Banking Services
- Investment Banking & Investment Services
- Insurance
- Collective Investments
- Investment Holding Companies
- Healthcare Equipment & Supplies
- Healthcare Providers & Services
- Pharmaceuticals
- Biotechnology & Medical Research
- Semiconductors & Semiconductor Equipment
- Communications & Networking
- Electronic Equipment & Parts
- Office Equipment
- Computers, Phones & Household Electronics
- Integrated Hardware & Software
- Software & IT Services
- Financial Technology (Fintech) & Infrastructure
- Telecommunications Services
- Electrical Utilities & IPPs
- Natural Gas Utilities
- Water & Related Utilities
- Multiline Utilities
- Real Estate Operations
- Residential & Commercial REITs
- Institutions, Associations & Organizations
- Government Activity
- Miscellaneous Educational Service Providers
- School, College & University
- Professional & Business Education
Quotes
Results: 23
Refine Results
Date
Date
Category
Provider
- All Providers
- Reuters
- Investing.com DNA 3rd party news
- Investing.com
- International Business Times
- Yahoo Finance
- FinanceMagnates
- Financial Times
- Forbes
- Bloomberg_video
- Business Insider
- Seeking Alpha
- Financial news 24
- Bloomberg
- DC Forecasts
- Cryptovest
- Cointelegraph
- AMBCrypto
- CoinDesk
- Crypto Globe
- blokt
- test
- The Conversation
- Allrates
- Money Show
- Euronews
- RealVision
- bizportal
- FX Street
- FX Empire
- Investing.com
- Investing.com
- Investing.com
- Crunchbase
- CoinEdition
- DailyCoin
- StockNews
- U.Today
- Investing.com
- Crypto.news
- Investing.com
- Quiver Quantitative
- Stock Story
- Chainwire
News
Please try another search
Results: 0
Tools & Sections
Results: 0
Authors
- Sign up for FREE and get:
- Real-Time Alerts
- Advanced Portfolio Features
- Personalized Charts
- Fully-Synced App